HEADER HYDROLASE 12-OCT-20 7ANQ TITLE COMPLETE PCSK9 C-TER DOMAIN IN COMPLEX WITH VHH P1.40 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEURAL APOPTOSIS-REGULATED CONVERTASE 1,NARC-1,PROPROTEIN COMPND 5 CONVERTASE 9,PC9,SUBTILISIN/KEXIN-LIKE PROTEASE PC9; COMPND 6 EC: 3.4.21.-; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: VHH P1.40 MINIBODY ANTI-CTER PCSK9; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PCSK9, NARC1, PSEC0052; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: LAMA GLAMA; SOURCE 11 ORGANISM_COMMON: LLAMA; SOURCE 12 ORGANISM_TAXID: 9844; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PCSK9, VHH P1.40, COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.CICCONE,P.LEGRAND,E.A.STURA,V.DIVE,N.G.SEIDAHN,C.FRUCHART GAILLARD REVDAT 3 07-FEB-24 7ANQ 1 REMARK REVDAT 2 25-JAN-23 7ANQ 1 JRNL REVDAT 1 20-OCT-21 7ANQ 0 SPRSDE 20-OCT-21 7ANQ 6F5G JRNL AUTH C.FRUCHART GAILLARD,A.B.D.OUADDA,L.CICCONE,E.GIRARD, JRNL AUTH 2 S.MIKAEELI,A.EVAGELIDIS,M.LE DEVEHAT,D.SUSAN-RESIGA, JRNL AUTH 3 E.C.LAJEUNESSE,H.NOZACH,O.H.P.RAMOS,A.THUREAU,P.LEGRAND, JRNL AUTH 4 A.PRAT,V.DIVE,N.G.SEIDAH JRNL TITL MOLECULAR INTERACTIONS OF PCSK9 WITH AN INHIBITORY NANOBODY, JRNL TITL 2 CAP1 AND HLA-C: FUNCTIONAL REGULATION OF LDLR LEVELS. JRNL REF MOL METAB V. 67 01662 2022 JRNL REFN ESSN 2212-8778 JRNL PMID 36566984 JRNL DOI 10.1016/J.MOLMET.2022.101662 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 988 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 49 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.22 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 404 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2436 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 384 REMARK 3 BIN R VALUE (WORKING SET) : 0.2387 REMARK 3 BIN FREE R VALUE : 0.3348 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.95 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 20 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2644 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 114 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04760 REMARK 3 B22 (A**2) : -0.04760 REMARK 3 B33 (A**2) : 0.09520 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.298 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.219 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.269 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.212 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2775 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3774 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 943 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 477 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2775 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 364 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3027 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.27 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.34 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { *|* } REMARK 3 ORIGIN FOR THE GROUP (A): -0.5648 18.5492 -9.5339 REMARK 3 T TENSOR REMARK 3 T11: -0.0426 T22: -0.0263 REMARK 3 T33: 0.0010 T12: -0.0378 REMARK 3 T13: -0.0026 T23: -0.0055 REMARK 3 L TENSOR REMARK 3 L11: 1.6107 L22: 1.0384 REMARK 3 L33: 1.3032 L12: -0.2297 REMARK 3 L13: -0.5003 L23: 0.3403 REMARK 3 S TENSOR REMARK 3 S11: 0.0227 S12: 0.1018 S13: -0.0127 REMARK 3 S21: -0.0350 S22: -0.0186 S23: 0.0214 REMARK 3 S31: -0.0064 S32: -0.0470 S33: -0.0041 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ANQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1292111729. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978570 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19768 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.196 REMARK 200 RESOLUTION RANGE LOW (A) : 48.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 11.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3H42, 4EIZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: PURIFIED PCSK9/P1.40 COMPLEX REMARK 280 AT 5.3 MG/ML PRECIPITANT: 10% PEG 4.000, 0.2M IMIDAZOLE MALATE, REMARK 280 PH 7.0 CRYOPROTECTANT: 40% SM3 (25 % DIETHYLENE GLYCOL + 25 % REMARK 280 ETHYLENE GLYCOL + 25 % GLYCEROL + 25 % 1,4-DIOXANE) 25% PEG REMARK 280 4.000, 0.2M IMIDAZOLE MALATE, PH 7.0, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 131.70500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 26.21500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 26.21500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 65.85250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 26.21500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 26.21500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 197.55750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 26.21500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 26.21500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 65.85250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 26.21500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 26.21500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 197.55750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 131.70500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 577 REMARK 465 VAL A 578 REMARK 465 LEU A 579 REMARK 465 ARG A 580 REMARK 465 PRO A 581 REMARK 465 ARG A 582 REMARK 465 GLY A 665 REMARK 465 SER A 666 REMARK 465 THR A 667 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 619 -149.59 57.90 REMARK 500 HIS A 643 64.31 65.98 REMARK 500 ASP A 651 -120.81 59.31 REMARK 500 ASP A 660 12.72 55.39 REMARK 500 ARG B 52 -97.58 -118.07 REMARK 500 ALA B 92 171.85 177.52 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ANQ A 452 682 UNP Q8NBP7 PCSK9_HUMAN 452 682 DBREF 7ANQ B 1 127 PDB 7ANQ 7ANQ 1 127 SEQRES 1 A 231 GLY TRP GLN LEU PHE CYS ARG THR VAL TRP SER ALA HIS SEQRES 2 A 231 SER GLY PRO THR ARG MET ALA THR ALA VAL ALA ARG CYS SEQRES 3 A 231 ALA PRO ASP GLU GLU LEU LEU SER CYS SER SER PHE SER SEQRES 4 A 231 ARG SER GLY LYS ARG ARG GLY GLU ARG MET GLU ALA GLN SEQRES 5 A 231 GLY GLY LYS LEU VAL CYS ARG ALA HIS ASN ALA PHE GLY SEQRES 6 A 231 GLY GLU GLY VAL TYR ALA ILE ALA ARG CYS CYS LEU LEU SEQRES 7 A 231 PRO GLN ALA ASN CYS SER VAL HIS THR ALA PRO PRO ALA SEQRES 8 A 231 GLU ALA SER MET GLY THR ARG VAL HIS CYS HIS GLN GLN SEQRES 9 A 231 GLY HIS VAL LEU THR GLY CYS SER SER HIS TRP GLU VAL SEQRES 10 A 231 GLU ASP LEU GLY THR HIS LYS PRO PRO VAL LEU ARG PRO SEQRES 11 A 231 ARG GLY GLN PRO ASN GLN CYS VAL GLY HIS ARG GLU ALA SEQRES 12 A 231 SER ILE HIS ALA SER CYS CYS HIS ALA PRO GLY LEU GLU SEQRES 13 A 231 CYS LYS VAL LYS GLU HIS GLY ILE PRO ALA PRO GLN GLU SEQRES 14 A 231 GLN VAL THR VAL ALA CYS GLU GLU GLY TRP THR LEU THR SEQRES 15 A 231 GLY CYS SER ALA LEU PRO GLY THR SER HIS VAL LEU GLY SEQRES 16 A 231 ALA TYR ALA VAL ASP ASN THR CYS VAL VAL ARG SER ARG SEQRES 17 A 231 ASP VAL SER THR THR GLY SER THR SER GLU GLY ALA VAL SEQRES 18 A 231 THR ALA VAL ALA ILE CYS CYS ARG SER ARG SEQRES 1 B 127 GLN VAL LYS LEU GLU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 B 127 ALA GLY GLY SER LEU ARG LEU SER CYS SER PRO SER ASP SEQRES 3 B 127 ARG THR PHE SER ALA TYR ALA MET GLY TRP PHE ARG GLN SEQRES 4 B 127 VAL PRO GLY ARG GLU ARG GLU PHE VAL ALA THR ILE ARG SEQRES 5 B 127 ASP SER ASP ALA SER ILE TYR TYR THR ASP SER VAL LYS SEQRES 6 B 127 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN THR SEQRES 7 B 127 VAL TYR LEU GLN MET ASN SER LEU ILE PRO ASP ASP THR SEQRES 8 B 127 ALA VAL TYR TYR CYS ALA ALA ARG GLN TYR TYR SER GLY SEQRES 9 B 127 ARG VAL TYR SER THR PHE ARG GLU GLU TYR ASP TYR TRP SEQRES 10 B 127 GLY GLN GLY THR GLN VAL THR VAL SER SER HET NAG C 1 14 HET NAG C 2 14 HET FUC C 3 10 HET SO4 A 701 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 3 FUC C6 H12 O5 FORMUL 4 SO4 O4 S 2- FORMUL 5 HOH *114(H2 O) HELIX 1 AA1 ASP B 62 LYS B 65 5 4 HELIX 2 AA2 ILE B 87 THR B 91 5 5 HELIX 3 AA3 PHE B 110 TYR B 114 5 5 SHEET 1 AA1 3 PHE A 456 TRP A 461 0 SHEET 2 AA1 3 TYR A 521 LEU A 528 -1 O CYS A 526 N ARG A 458 SHEET 3 AA1 3 GLU A 482 PHE A 489 -1 N GLU A 482 O CYS A 527 SHEET 1 AA2 3 THR A 472 ALA A 475 0 SHEET 2 AA2 3 LYS A 506 ASN A 513 -1 O CYS A 509 N ALA A 475 SHEET 3 AA2 3 ARG A 495 GLN A 503 -1 N GLN A 503 O LYS A 506 SHEET 1 AA3 3 ASN A 533 ALA A 539 0 SHEET 2 AA3 3 SER A 595 HIS A 602 -1 O CYS A 600 N SER A 535 SHEET 3 AA3 3 VAL A 558 HIS A 565 -1 N HIS A 565 O SER A 595 SHEET 1 AA4 2 THR A 548 HIS A 551 0 SHEET 2 AA4 2 GLN A 587 GLY A 590 -1 O CYS A 588 N VAL A 550 SHEET 1 AA5 3 LEU A 606 ILE A 615 0 SHEET 2 AA5 3 VAL A 672 SER A 681 -1 O ALA A 676 N LYS A 611 SHEET 3 AA5 3 THR A 631 ALA A 637 -1 N SER A 636 O VAL A 675 SHEET 1 AA6 3 GLN A 621 ALA A 625 0 SHEET 2 AA6 3 THR A 653 SER A 658 -1 O CYS A 654 N VAL A 624 SHEET 3 AA6 3 VAL A 644 VAL A 650 -1 N VAL A 650 O THR A 653 SHEET 1 AA7 4 LEU B 4 SER B 7 0 SHEET 2 AA7 4 LEU B 18 PRO B 24 -1 O SER B 23 N GLU B 5 SHEET 3 AA7 4 THR B 78 MET B 83 -1 O MET B 83 N LEU B 18 SHEET 4 AA7 4 PHE B 68 ASP B 73 -1 N ASP B 73 O THR B 78 SHEET 1 AA8 6 GLY B 10 GLN B 13 0 SHEET 2 AA8 6 THR B 121 SER B 126 1 O THR B 124 N GLY B 10 SHEET 3 AA8 6 ALA B 92 ARG B 99 -1 N TYR B 94 O THR B 121 SHEET 4 AA8 6 ALA B 33 GLN B 39 -1 N PHE B 37 O TYR B 95 SHEET 5 AA8 6 GLU B 46 ILE B 51 -1 O GLU B 46 N ARG B 38 SHEET 6 AA8 6 TYR B 59 TYR B 60 -1 O TYR B 59 N THR B 50 SHEET 1 AA9 4 GLY B 10 GLN B 13 0 SHEET 2 AA9 4 THR B 121 SER B 126 1 O THR B 124 N GLY B 10 SHEET 3 AA9 4 ALA B 92 ARG B 99 -1 N TYR B 94 O THR B 121 SHEET 4 AA9 4 TYR B 116 TRP B 117 -1 O TYR B 116 N ALA B 98 SSBOND 1 CYS A 457 CYS A 527 1555 1555 2.04 SSBOND 2 CYS A 477 CYS A 526 1555 1555 2.04 SSBOND 3 CYS A 486 CYS A 509 1555 1555 2.03 SSBOND 4 CYS A 534 CYS A 601 1555 1555 2.05 SSBOND 5 CYS A 552 CYS A 600 1555 1555 2.04 SSBOND 6 CYS A 562 CYS A 588 1555 1555 2.04 SSBOND 7 CYS A 608 CYS A 679 1555 1555 2.02 SSBOND 8 CYS A 626 CYS A 678 1555 1555 2.03 SSBOND 9 CYS A 635 CYS A 654 1555 1555 2.04 SSBOND 10 CYS B 22 CYS B 96 1555 1555 2.04 LINK ND2 ASN A 533 C1 NAG C 1 1555 1555 1.43 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.43 LINK O6 NAG C 1 C1 FUC C 3 1555 1555 1.40 CRYST1 52.430 52.430 263.410 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019073 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019073 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003796 0.00000